Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Farlow

Showing results (91-100 of 189) with videos related to

Pageof 19
Sort By:
Rapid Communications in Mass Spectrometry : RCM|November 23, 2006
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometryTomoyuki Oe, Bradley L Ackermann, Koichi Inoue, et al.
The American Journal of Geriatric Pharmacotherapy|December 13, 2006
Recommendations for best practices in the treatment of Alzheimer's disease in managed careHoward M Fillit, Rachelle Smith Doody, Kimberly Binaso, et al.
The American Journal of Psychiatry|May 3, 2003
A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's diseaseGeorge S Zubenko, Wendy N Zubenko, Susan McPherson, et al.
Pharmacogenetics and Genomics|March 13, 2008
Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's diseaseRoger Lane, Howard H Feldman, Joanne Meyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2025
The Cognitive Change Index in the Alzheimer's Disease Research Center setting: Self- and informant-ratings for perceived cognitive declineYousaf Abughofah, Shannon L Risacher, Frederick W Unverzagt, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
BrainAGE Estimation: Influence of Field Strength, Voxel Size, Race, and EthnicityDesarae A Dempsey, Rachael Deardorff, Yu-Chien Wu, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 22, 2017
Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomographyShannon L Risacher, Eileen F Tallman, John D West, et al.
Stem Cells (Dayton, Ohio)|November 22, 2008
IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal ratsXing Wei, Zhimei Du, Liming Zhao, et al.
Journal of Alzheimer'S Disease : JAD|December 11, 2022
Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's DiseaseSunu Mathew, Darrell WuDunn, Devin D Mackay, et al.
Neurobiology of Aging|September 10, 2013
Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjectsSteven P Millard, Franziska Lutz, Ge Li, et al.
Pageof 19

Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
Rapid Communications in Mass Spectrometry : RCM|November 23, 2006
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometryTomoyuki Oe, Bradley L Ackermann, Koichi Inoue, et al.
The American Journal of Geriatric Pharmacotherapy|December 13, 2006
Recommendations for best practices in the treatment of Alzheimer's disease in managed careHoward M Fillit, Rachelle Smith Doody, Kimberly Binaso, et al.
The American Journal of Psychiatry|May 3, 2003
A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's diseaseGeorge S Zubenko, Wendy N Zubenko, Susan McPherson, et al.
Pharmacogenetics and Genomics|March 13, 2008
Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's diseaseRoger Lane, Howard H Feldman, Joanne Meyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2025
The Cognitive Change Index in the Alzheimer's Disease Research Center setting: Self- and informant-ratings for perceived cognitive declineYousaf Abughofah, Shannon L Risacher, Frederick W Unverzagt, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
BrainAGE Estimation: Influence of Field Strength, Voxel Size, Race, and EthnicityDesarae A Dempsey, Rachael Deardorff, Yu-Chien Wu, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 22, 2017
Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomographyShannon L Risacher, Eileen F Tallman, John D West, et al.
Stem Cells (Dayton, Ohio)|November 22, 2008
IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal ratsXing Wei, Zhimei Du, Liming Zhao, et al.
Journal of Alzheimer'S Disease : JAD|December 11, 2022
Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's DiseaseSunu Mathew, Darrell WuDunn, Devin D Mackay, et al.
Neurobiology of Aging|September 10, 2013
Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjectsSteven P Millard, Franziska Lutz, Ge Li, et al.
Pageof 19